Announcements and Notices - [Other - Business Update]

Hansoh Pharmaceutical Group Company Limited operates as a pharmaceutical company. The Company manufactures and sells anti-infectives, anti-neoplastic agents, diabetes drugs, and other products. Hansoh Pharmaceutical Group markets its products throughout China.

Voluntary Announcement -
The Nmpa Has Granted Breakthrough-Therapy-Designated
Drug For B7-H3-Targeted Antibody-Drug Conjugate Hs-20093

Voluntary Announcement -
Ameile Phase Iii Clinical Trial Met The Primary Endpoint
In Combination With Chemotherapy For Patients With
Locally Advanced Or Metastatic Egfr-Mutated Nsclc

Notification Letter And Request Form To Non-Registered Holders

Notification Letter And Reply Form To Registered Shareholders

Financial Statements/ESG Information - [Interim/Half-Year Report]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Hansoh Pharmaceutical Group (3692 HK)

Voluntary Announcement - The Nmpa Has Granted Breakthrough-Therapy-Designated Drug For B7-H3-Targeted Antibody-Drug Conjugate Hs-20093

Voluntary Announcement - Ameile Phase Iii Clinical Trial Met The Primary Endpoint In Combination With Chemotherapy For Patients With Locally Advanced Or Metastatic Egfr-Mutated Nsclc

Notification Letter And Request Form To Non-Registered Holders

Notification Letter And Reply Form To Registered Shareholders

Interim Report 2024

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)